Cargando…
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
An effective vaccine is a priority for malaria control and elimination. The leading candidate in the Plasmodium falciparum blood stage is PfRh5. PfRh5 assembles into trimeric complex with PfRipr and PfCyRPA in the parasite, and this complex is essential for erythrocyte invasion. In this study, we sh...
Autores principales: | Healer, Julie, Wong, Wilson, Thompson, Jennifer K., He, Wengqiang, Birkinshaw, Richard W., Miura, Kazutoyo, Long, Carol A., Soroka, Vladislav, Søgaard, Teit Max Moscote, Jørgensen, Thomas, de Jongh, Willem A., Weir, Christopher, Svahn, Ella, Czabotar, Peter E., Tham, Wai‐Hong, Mueller, Ivo, Barlow, Paul N., Cowman, Alan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594224/ https://www.ncbi.nlm.nih.gov/pubmed/30965383 http://dx.doi.org/10.1111/cmi.13030 |
Ejemplares similares
-
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
por: Ragotte, Robert J., et al.
Publicado: (2020) -
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
por: Knuepfer, Ellen, et al.
Publicado: (2019) -
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
por: Healer, Julie, et al.
Publicado: (2022) -
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
por: Chen, Lin, et al.
Publicado: (2017) -
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
por: Azasi, Yvonne, et al.
Publicado: (2020)